Navigation Links
Long-term safety data on Lialda published in leading GI journal
Date:6/17/2008

ment-related AEs were experienced by a total of 10.2 percent of patients [11.1 percent of patients (n=225) in the once-daily group and 9.4 percent of patients (n=234) in the twice-daily group]. A total of 3.9 percent of patients experienced serious AEs [4 percent of patients (n=225) in the once-daily group and 3.8 percent of patients (n=234) in the twice-daily group], most of which were gastrointestinal disorders, and only one serious AE was considered to be related to study treatment.

The secondary endpoints of the study evaluated maintenance of remission and relapse rates over 12 months. In the efficacy population at entry (month 0), 78.1 percent of patients (n=219) in the once-daily group and 82.3 percent of patients (n=232) in the twice-daily group were in clinical and endoscopic remission. At month 12, 64.4 percent of patients in the once-daily and 68.5 percent of patients in the twice-daily group were in strictly defined clinical and endoscopic remission (P=0.351). Thus, there was no significant difference between the once-daily and twice-daily groups with respect to strictly defined clinical and endoscopic remission at month 12. Further, 88.9 percent and 93.2 percent of patients in each group, respectively, had maintained clinical remission and were considered "relapse-free".

Study Background

A total of 459 patients were enrolled and randomized in the 303 long-term safety study (246 directly from the parent studies 301 and 302 - Lialda's eight-week, Phase III, placebo-controlled trials that demonstrated efficacy for the induction of remission in active, mild to moderate UC - and 213 patients who received an additional 8 weeks of treatment with Lialda 4.8 g/day to induce remission). Remission was defined using stringent clinical and endoscopic measures: modified UC Disease Activity Index (UC-DAI) score of ≤1, with scores of 0 for rectal bleeding and stool frequency, and a combined Physician's Global Assessment and sigmoidos
'/>"/>

Contact: Blythe Bertolo
bbertolo@golinharris.com
312-729-4463
Shire plc
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal
2. Some patients may not need insulin for long-term control of type 2 diabetes
3. New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
4. Social Security Statement Advises Seniors to Consider Private Long-Term Care Insurance, LTC Agency Reports; Medicare Wont Cover It
5. Treatment at an AASM accredited sleep center improves long-term CPAP compliance
6. Poor sleep a problem in long-term breast cancer survivors
7. Long-term pesticide exposure may increase risk of diabetes
8. Long-term bouts with hay fever worsen ability to breathe through your nose
9. Keane Wins $1.5 Million Electronic Medical Record (EMR) Implementation with Leading Long-Term Care Company
10. Long-term hormone replacement therapy increases breast cancer risk
11. Study concludes no racial disparities in long-term outcomes in recipients of liver transplants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 22, 2015 Padre Murphy's and Owner Tom ... Pro Player Health Alliance (PPHA). The PPHA's passion ... getting everyone, including NFL greats, treated for obstructive sleep apnea ... groups supporting the cause in the valley. The most recent ...
(Date:1/22/2015)... 23, 2015 AngelWeddingDress, the premier women’s ... maternity wedding dresses. View website of AngelWeddingDress.com ... for maternity wedding dresses online for a bridal party. ... high quality for them. Its maternity wedding dresses are ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post ... insurance policy . , Auto insurance quotes help many ... no longer necessary to call an agent or visit an ... on a single website: http://autocarinsurancebest.com/ . , Every business ...
(Date:1/22/2015)... Jolla, Calif. (PRWEB) January 22, 2015 ... Assemblymembers Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) ... for their leadership in advancing biotechnology, biomedical science, ... Bonilla and Olsen each received the “2014 Life ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and ... relationship in an effort to further promote visibility and adoption ... has long made AMA journals available via its subscription services, ... JAMA Network. , Long known as both a ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... radar breast imaging system developed at Bristol University that ... cancer, is being trialled at North Bristol NHS Trust ... from the University of Bristol have been working for ... which uses radio waves and therefore has no radiation ...
... AGGIE 100 HONOREES, COLLEGE STATION, Texas, Nov. ... from the 4th annual "Aggie 100",list of the ... former students. Clarus Imaging Center of Houston, Oprex ... are among the firms,selected for the award. The ...
... Inc. (OTC Bulletin Board: HTEC) announced today that ... International, LLC, a private,marketing firm, to form a ... Hydron Technologies has been developing products for healthcare,professionals ... non-occlusive,polymer that binds moisture and other ingredients to ...
... growing consumer desire for greater control and,security, ... to evolve a new,generation of whole life ... today announced the introduction of updated,versions of ... and increased,flexibility for policyholders., To view ...
... 3 to 5 years of standard shots under skin, ... A Swiss-led study appears to point the way toward ... pollen allergy by using direct injections into the lymph ... several years and involving dozens of injections, the new ...
... be a silver -- and healthy -- lining to ... and itching just may help prevent cancer -- particularly ... and gastrointestinal tract cancer, according to a new Cornell ... directly with the external environment," said Paul Sherman, Cornell ...
Cached Medicine News:Health News:New technology could revolutionize breast cancer screening 2Health News:New technology could revolutionize breast cancer screening 3Health News:Altus Healthcare Management Systems' Oprex Surgery Center, Clarus Imaging Center & Zerenity Sleep Lab of Houston 2Health News:Hydron Technologies, Inc. and Brand Builders International, LLC Join Forces to Form New Entity 2Health News:Hydron Technologies, Inc. and Brand Builders International, LLC Join Forces to Form New Entity 3Health News:Video: MassMutual Enhances Whole Life Insurance Products - Provides Flexibility, Guarantees 2Health News:Video: MassMutual Enhances Whole Life Insurance Products - Provides Flexibility, Guarantees 3Health News:Lymph Node Shots Tested for Grass Pollen Allergy 2Health News:Lymph Node Shots Tested for Grass Pollen Allergy 3Health News:The miseries of allergies just may help prevent some cancers, study finds 2Health News:The miseries of allergies just may help prevent some cancers, study finds 3
(Date:1/23/2015)... Inc. (ICBU) has repositioned itself as a holding company with ... in the hydroponic, hemp and medical marijuana sectors. By acquiring ... sector, and recently partnering with the Chippewa Tribe Nation to ... iMD is committing to bring its vision to the market ...
(Date:1/23/2015)... Jan. 23, 2015 Cord Blood America, Inc. ( www.cordblood-america.com ... the "Company")  filed a Preliminary Proxy Statement, Schedule 14A, with ... and provides an update for shareholders detailing why a "YES" ... Dear Shareholders, As we reflect upon ...
(Date:1/23/2015)... , Jan. 23, 2015  CytoSorbents Corporation (NASDAQ CM: ... CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation ... receipt of $385,642, net of transaction costs, in ... Technology Business Tax Certificate Transfer Program sponsored by ...
Breaking Medicine Technology:iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3
The flexible EXXCEL ePTFE Vascular Access Graft material is designed to offer textile-like handling characteristics-cuts neatly for a clean edge, retains fully open lumen shape, and sutures smoothly....
... intended for monitoring the accuracy and precision of ... in vitro diagnostic use only. Provided in a ... up to ten days stability at 2 ... used in accordance with the directions accompanying the ...
PowerMed is a billing software....
Managed care is a billing and tracking system....
Medicine Products: